Latest Sequenom Inc (SQNM) Headlines US Non-Inv
Post# of 42
Posted On: 03/13/2014 2:18:00 PM
Latest Sequenom Inc (SQNM) Headlines
US Non-Invasive Prenatal Diagnostics - Market Insight - 2013 Report: Focusing on Players such as Sequenom, Verinata, Ariosa and Natera
M2 - Tue Mar 11, 7:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bkvmt4/us_noninvasive) has announced the addition of the "US Non-Invasive Prenatal Diagnostics - Market Insight" report to their offering. The US prenatal diagnostics market is one of the largest markets in the world for foetal monitoring, diagnostics, and predictive testing. It consists of a series of physician prescribed tests for monitoring maternal and foetal health. The current invasive technologies such as CVS and amniocentesis that are used to detect chromosomal abnormalities pose serious risks of miscarriages and are being replaced by the non-invasive prenatal diagnostics technologies. Although NIPD is a relatively nascent segment of the prenatal diagnostics, it presents a lucrative growth potential to industry participants. The segment is mainly supported by rising incidences of foetal health-related abnormalities and the urgent need for safe, accurate and early diagnosis. Products such as MaterniT21 Plus, Verifi, and Harmony prenatal tests are the current tests available in the market. Around 100,000 samples were likely tested by MaterniT21 plus test alone by the first quarter of 2013 since its launch. Further the report US Non-Invasive Prenatal Diagnostics - Market Insight, provides a transparent view on the present regulatory framework elaborating on the existing loopholes. A thorough analysis has been done illustrating the views of regulatory authorities, players and consumers towards the regulatory stringency, and the direction of regulations in the future have also been covered. Currently, the US NIPD sector is characterized by the presence of players like Sequenom, Verinata, Ariosa and Natera. These companies are effectively taking steps to promote their LDTs among the US population especially targeting physicians to recommend their products. In future, the launch of Natera's test is expected to impact the market significantly, thereby boosting the potential size and sample volume. Companies Mentioned: - Ariosa Diagnostics - Natera - Sequenom - Verinata For more information visit http://www.researchandmarkets.com/research/bk...oninvasive About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
2014 Analysis of the UK Hepatitis Diagnostics Market: Hospitals, Blood Banks, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
M2 - Mon Mar 10, 6:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rjsvbf/2014_analysis_of) has announced the addition of the "2014 Analysis of the UK Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures" report to their offering. The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals - Commercial/Private Labs - Blood Banks - Public Health Labs In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio/Innogenetics - Hologic/Gen-Probe - ID Biomedical/GSK - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics/Grifols - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/rj...nalysis_of About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Sequenom Announces Changes In Company Leadership
PR Newswire - Wed Mar 05, 6:00PM CST
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that Harry F. Hixson, Jr., Ph.D., will retire as Chief Executive Officer (CEO), effective as of the Company's 2014 Annual Meeting on June 10, 2014. William J. Welch, the Company's current President and Chief Operating Officer, will assume the role of CEO, effective as of the Annual Meeting and immediately upon Dr. Hixson's retirement as CEO.
Sequenom, Inc. Announces Participation At The 26th Annual Roth Conference
PR Newswire - Mon Mar 03, 6:00AM CST
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the 26th Annual Roth Conference at the Ritz Carlton in Dana Point, CA on March 9-12, 2014.
Why Sequenom (SQNM) Closed Lower on Friday
at The Street - Fri Feb 28, 3:45PM CST
Sequenom (SQNM) closed lower on Friday after quarterly revenue came in below expectations.
Hot Stock: Sequenom, Shares Drop 9.1% (SQNM)
Comtex SmarTrend(R) - Fri Feb 28, 10:13AM CST
Sequenom (NASDAQ:SQNM) is one of today's worst performing low-priced stocks, down 9.1% to $2.34 on 1.0x average daily volume. Sequenom has traded 2.0 million shares thus far today, vs. average volume of 1.9 million shares per day. The stock has underperformed the Dow (-9.1% to the Dow's 0.6%) and underperformed the S&P 500 (-9.1% to the S&P's 0.6%) during today's trading.
Concise Analysis of the International Genetic Testing Market
M2 - Fri Feb 28, 8:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/8z6k4n/global_genetic) has announced the addition of the "Concise Analysis of the International Genetic Testing Market" report to their offering. Currently, DTC genetic testing is the buzz word in the Global Genetic Testing market. DTC genetic testing refers to genetic tests that are marketed directly to consumers through television, print advertisements, or the internet. This form of testing, which is also called at-home genetic testing, provides access to a person's genetic information without the involvement of the consumer's healthcare provider. The DTC test typically includes collecting a DNA sample at home, often by swabbing the inside lining of the cheek, and mailing the sample back to the laboratory. Consumers are notified of their results by e-mail, over the phone, or the results are posted online on the websites of the offering companies. DTC genetic tests are expected to have a positive impact on the growth of the market during the forecast period. According to the report, one of the main drivers in this market is the increase in the aging population worldwide. The increasing prevalence of diseases such as diabetes, obesity, and cancer among the elderly population is contributing to the growth of the market. Further, the report states that one of the major challenges in the market is the lack of a credible standard procedure to evaluate the analytic and clinical validity of genetic tests. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Key Leading Countries 9. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis Companies Mentioned: - Abbott Laboratories - Agilent Technologies Inc. - Clarient Inc. - Genomic Health Inc. - Hologenic Inc. - Myriad Genetics Inc. - Qiagen N.V. - Quest Diagnostics Inc. - Roche Holding AG - Sequenom Inc. - Transgenomic Inc. - bioM?rieux SA For more information visit http://www.researchandmarkets.com/research/8z...al_genetic
Sequenom's Q4 Loss Narrows 42% on Higher Laboratory Revenue
Sean Williams, The Motley Fool - Motley Fool - Thu Feb 27, 4:14PM CST
Small-cap life science company Sequenom reported its fourth-quarter earnings results after the closing bell tonight, highlighting a push toward smaller losses and lower cash burn. For the quarter, Sequenom reported a 34% increase in revenue to...
Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year Of 2013
PR Newswire - Thu Feb 27, 3:10PM CST
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today reported total revenues of $45.1 million for the fourth quarter and $162.4 million for the full year of 2013. Net loss was $18.9 million, or $0.16 per share, for the fourth quarter and $107.4 million, or $0.93 per share, for the full year.
3 Biotech Stocks Under $10 to Trade for Breakouts
at The Street - Wed Feb 26, 5:00AM CST
These under-$10 biotech stocks are within range of triggering breakout trades.
Emerging Indian NIPT Market: 2014 Report Reveals that in India, NIPT Will Be Eagerly Adopted by the Booming IVF Clinics
M2 - Tue Feb 25, 12:10PM CST
Research and Markets (http://www.researchandmarkets.com/research/p8gdfv/emerging_indian) has announced the addition of the "Emerging Indian NIPT Market" report to their offering. In the latest research study Emerging Indian NIPT Market, the analysts have identified various factors to showcase the immense potential of the Indian NIPT market. These factors like the number of births by the age of mother, rural and urban split of such births; affordability for NIPT; and regulatory scenario have been prudently analyzed to reflect a clear picture of the immense possibilities in the Indian NIPT market. The report provides a depiction of macro-economic factors and healthcare infrastructure relevant in the context of NIPT. The study reveals that in India, NIPT will be eagerly adopted by the booming IVF clinics that are witnessing a huge surge in fertility tourism. Also, India is home to a rapidly expanding network of pathology labs. In order to differentiate themselves from competition, organized players in the Indian diagnostic services market are looking forward to adopting new tests. RNCOS has used its expertise in the Indian IVF and diagnostic services market to provide a relevant snapshot of these markets in the report. Leading players in both markets have been profiled with details about their infrastructure and analysis of their strengths and weaknesses, which will prove to be of value to NIPT players looking for partnering opportunities in India. Besides, to offer a glimpse of NIPT players in the global market to the diagnostic services players looking forward for partnerships and collaborations, detailed profiling of NIPT players, including the description of their test offering along with strengths and weaknesses analysis of their NIPT business has been provided. The report also includes the findings from another RNCOS survey namely Gynecologists survey to assess the potential for NIPT in India. The survey was done between September-December 2012 with around 100 leading gynecologists in India. The key findings reveal that currently the awareness level of NIPT is very low in India. But when made aware about the benefits of NIPT, all gynecologists agreed that if launched tactfully, such a technology would have a tremendous scope to revolutionize the prenatal diagnosis scenario in India. Companies Mentioned: -Ariosa Diagnostics -Berry Genomics -BGI -Dr. Lal Pathlabs -Metropolis India -Natera -Quest Diagnostics -Sequenom -SRL Diagnostics -Thyrocare -Verinata For more information visit http://www.researchandmarkets.com/research/p8...ing_indian About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Prenatal Testing Market in the US 2014-2018: Perkinelmer Inc. Expands its Screening Test Offerings, Introducing the First Early Onset Preeclampsia Screening Test in the US in 2013
M2 - Tue Feb 25, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/x2lvh8/prenatal_testing) has announced the addition of the "Prenatal Testing Market in the US 2014-2018" report to their offering. The analysts forecast the Prenatal Testing market in the US to grow at a CAGR of 5.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of fetal health-related abnormalities. The Prenatal Testing market in the US has also been witnessing the significant increase in the launch of new tests. However, the falling fertility rates in the US could pose a challenge to the growth of this market. Key vendors dominating this space are PerkinElmer Inc., Quest Diagnostics Inc., Sequenom Inc., and Verinata Health Inc. Other vendors mentioned in the report are ANGLE plc, Ariosa Diagnostics Inc., BGI Health, CellScape Corp., Fluidigm Corp., Ikonisys Inc., Kellbenx Inc., Natera Inc., Ravgen Inc., and Trovagene Inc. Commenting on the report, an analyst from the team said: The Prenatal Testing market in the US is experiencing a significant increase in the number of new tests being launched in the market. For instance, Sequenom launched Laboratoire Cerba's non-invasive prenatal test in San Diego, California, and Saint-Ouen-L'Aumone, France, in December 2013 and enhanced the sequencing series for its MaterniT21 PLUS laboratory-developed test in October 2013. Moreover, PerkinElmer Inc. expanded its prenatal screening test offerings, introducing the first early onset preeclampsia screening test in the US in August 2013. This trend will have a positive impact on the growth of the market. According to the report, one of the major factors driving the market is the increase in the incidence of fetal abnormalities such as Down syndrome, Edwards syndrome, neural tube defects, and genetic defects and disorders such as sickle cell anemia, thalassemia, spina bifida, Tay Sachs disease, cystic fibrosis, muscular dystrophy, cleft palate and fragile X syndrome. For more information visit http://www.researchandmarkets.com/research/x2...al_testing About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Respiratory Diseases in the US 2014: Market Outlook and Emerging Opportunities
M2 - Fri Feb 21, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/3tw5kb/respiratory) has announced the addition of the "Respiratory Diseases in the US 2014: Market Outlook and Emerging Opportunities" report to their offering. This new 283-page report presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for microbiology testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.. Methodology - The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. - In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as the author's proprietary data files was conducted. Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - BioRad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio - GenProbe - Hologic - ID Biomedical Innogenetics/Solvay - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics - OrthoClinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac - Wako For more information visit http://www.researchandmarkets.com/research/3t...espiratory About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
2014 Automated Microbiology Market -- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Blood Culture, Urine Screening and Immunodiagnostics
M2 - Tue Feb 18, 8:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/48jvmv/2014_automated) has announced the addition of the "2014 Automated Microbiology Market -- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report to their offering. '2014 Automated Microbiology Market--A Global Strategic Outlook' is a new seven-country strategic analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, and country; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies. Worldwide Market Overview - Estimated universe of laboratories performing microbiology testing by country. - Specimen, test volume and sales forecasts by country. Market Segmentation Analysis - Sales and market shares for major suppliers by individual test and country. - Volume and sales forecasts for over 100 infectious disease assays by individual test and country. - Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy). - Review of the market dynamics, trends, structure, size, growth and major suppliers by country Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Exact Sciences - Fujirebio/Innogenetics - Hologic/Gen-Probe - Illumina - ID Biomedical/GSK - Kreatech - Li-Cor Biosciences - Life Technology - Lonza - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Novartis Diagnostics/Grifols - Orchid CellMark - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Sierra Molecular - Shimadzu - Takara Bio - Tecan - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/48..._automated About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Respiratory Diseases in the UK 2014: Market Outlook and Emerging Opportunities Available Now for Analysis
M2 - Mon Feb 17, 6:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/38644v/respiratory) has announced the addition of the "Respiratory Diseases in the UK 2014: Market Outlook and Emerging Opportunities" report to their offering. This new 281-page report presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for microbiology testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology - The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. - In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as the author's proprietary data files was conducted. Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - BioRad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio - GenProbe - Hologic - ID Biomedical Innogenetics/Solvay - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics - OrthoClinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac - Wako For more information visit http://www.researchandmarkets.com/research/38...espiratory About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2013 Financial Results And Conference Call
PR Newswire - Thu Feb 13, 6:00AM CST
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the fourth quarter and full year of 2013 after closing of the NASDAQ Global Market on Thursday, February 27, 2014.
2014 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts
M2 - Thu Feb 13, 3:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/8tlq3p/2014_analysis_of) has announced the addition of the "2014 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts " report to their offering. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals - Commercial/Private Labs - Blood Banks - Physician Offices - Public Health Labs For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Key Topics Covered: I. Introduction II. Hepatitis Worldwide Market and Technology Overview III. France: Market Size, Growth and Major Suppliers' Sales and Market Shares IV. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares V, Italy: Market Size, Growth and Major Suppliers' Sales and Market Shares VI. Spain: Market Size, Growth and Major Suppliers' Sales and Market Shares VII. UK: Market Size, Growth and Major Suppliers' Sales and Market Shares X. Alternative Market Penetration Strategies XI. Potential Market Entry Barriers and Risks XII. Competitive Assessments Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio/Innogenetics - Hologic/Gen-Probe - ID Biomedical/GSK - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/8t...nalysis_of
2014 Analysis of the US Hospital Cancer Diagnostics Market
M2 - Thu Feb 13, 3:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/g5hk8t/2014_analysis_of) has announced the addition of the "2014 Analysis of the US Hospital Cancer Diagnostics Market" report to their offering. This new report contains 533 pages, 43 tables, and presents a comprehensive analysis of the US hospital cancer diagnostics market, including: - Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. - Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. - Test volume and sales forecasts for 40 cancer diagnostic procedures performed in French hospitals. - Current instrumentation technologies and feature comparison of leading analyzers. - Sales and market shares of leading suppliers. - Emerging diagnostic technologies and their potential market applications. - Product development opportunities. - Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. - Business opportunities and strategic recommendations for suppliers. Key Topics Covered: Introduction Worldwide Market and Technology Overview A. Cancer Statistics and Etiology B. Major Current And Emerging Cancer Diagnostic Tests C. Instrumentation Review And Market Needs D. Current and Emerging Technologies US A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers Major Product Development Opportunities A. Reagent Kits and Test Systems/Panels B. Instrumentation C. Computers, Software and Automation D. Auxiliary Products Design Criteria for Decentralized Testing Products Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies 1. Marketing Approaches 2. Product Complexity 3. Customer Preference 4. Established Suppliers 5. Emerging Suppliers 6. Major Types of Distributors 7. Market Segmentation Factor Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges Companies Mentioned: - Abbott - AdnaGen - Applied Gene Technologies - Arca - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics - bioMerieux - Bio-Rad - Cepheid - Correlogic Systems - Dako - Decode - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Enterix - Enzo Biochem - Epigenomics - Exact Sciences - Fujirebio - Gen-Probe - Guided Therapeutics - Hologic - Ipsogen - Kreatech - Kyowa Medex - Life Technologies - Mackay Life Sciences - Myriad Genetics - Nanogen Elitech - OncoLab - Otho-Clinical Diagnostics - Panacea Pharmaceuticals - Polartechnics - Polymedco - PreMD - Qiagen - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/g5...nalysis_of
Genetic Testing Market Likely to Grow at a CAGR of Around 9% During 2012-2017
M2 - Tue Feb 11, 9:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/qnk984/genetic_testing) has announced the addition of the "Genetic Testing Market Outlook to 2017" report to their offering. A recent report, Genetic Testing Market Outlook to 2017, provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principles and types are covered in around a 140-page report. On account of our analysis of the past and present market trends; drivers; and existing strengths and challenges; forecast for genetic testing has been drawn, according to which, the market is likely to grow at a CAGR of around 9% during 2012-2017. The report is an outcome of extensive interaction with industry experts which has led us to portray the updated status of genetic testing in various therapeutic areas, major geographies and significant industry applications. The genetic testing industry has seen several new product launches, active research innovations, strategic activities, launch of new DTC tests, and wider therapeutic applications. The report effectively illustrates the role of genetic testing in diseases such as Cancer, Cystic Fibrosis and Alzheimer. It also incorporates the information on disease prevalence, available tests, and genes that cause a particular disease. An extensive research and reliable statistics in terms of market size, developments and future performance for emerging sectors namely, Next-Generation Sequencing, Whole Genome Sequencing, Non Invasive Prenatal Diagnostics, and Personalized Medicine have been covered in the report. Genetic testing is growing in both developing and developed nations with both industry and research personnel highlighting the significance of molecular biology. The report provides comprehensive analytics of key developments for major markets including the U.S., Europe and Asian countries, and their market overview. Country level analysis depicts the level of penetration for genetic testing, types of tests available, consumer perspectives, regulatory stringency and future growth. Companies Mentioned: - Abbott Laboratories - Clarient (GE Healthcare) - Dako (Agilent Technologies) - Genomic Health - Genoptix (Novartis) - Gen-Probe (Hologic) - Life Technologies Corporation - Myriad Genetics - Quest Diagnostics - Roche Diagnostics - Sequenom - Transgenomic For more information visit http://www.researchandmarkets.com/research/qn...ic_testing About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
2014 Analysis of the World Cancer Diagnostic Testing Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
M2 - Mon Feb 10, 2:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/r66j8d/2014_analysis_of) has announced the addition of the "2014 Analysis of the World Cancer Diagnostic Testing Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities" report to their offering. This new report contains 1,200 pages, 450 tables and provides forecasts for 40 tumor markers by country and market segment, as well as sales and market shares for reagent and instrument suppliers. The report is available by region, country, section, market segment and individual test: Regions: Global, Europe Countries: France, Germany, Italy, Japan, Spain, UK, USA Sections: Assays, Competitors, Instrumentation, Technologies Market Segments: Hospitals (France, Germany, Italy, Japan, Spain, UK, USA), Personalized Testing Tests: AFP, Beta-2 Microglobulin,CA Tumor Markers, CEA, Cell Surface Markers, Occult Blood, PAP, Pap Smear/HPV, PSA To purchase a DataPack that includes (test volumes, sales forecasts, supplier shares) please E-mail us. Key Topics Covered: Introduction Worldwide Market and Technology Overview A. Cancer Statistics and Etiology B. Major Current And Emerging Cancer Diagnostic Tests C. Instrumentation Review And D. Current and Emerging Technologies Competitive Profiles - Abbott - AdnaGen - Applied Gene Technologies - Arca - Beckman Coulter/Danaher - Becton Dickinson - Bio-Rad - Biomedical Diagnostics - Cepheid - Correlogic Systems - Dako - Decode - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Enterix - Enzo Biochem - Epigenomics - Exact Sciences - Fujirebio - Gen-Probe - Guided Therapeutics - Hologic - Ipsogen - Kreatech - Kyowa Medex - Life Technologies - Mackay Life Sciences - Myriad Genetics - Nanogen Elitech - OncoLab - Otho-Clinical Diagnostics - Panacea Pharmaceuticals - Polartechnics - Polymedco - PreMD - Qiagen - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila - bioMerieux For more information visit http://www.researchandmarkets.com/research/r6...nalysis_of About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
US Non-Invasive Prenatal Diagnostics - Market Insight - 2013 Report: Focusing on Players such as Sequenom, Verinata, Ariosa and Natera
M2 - Tue Mar 11, 7:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bkvmt4/us_noninvasive) has announced the addition of the "US Non-Invasive Prenatal Diagnostics - Market Insight" report to their offering. The US prenatal diagnostics market is one of the largest markets in the world for foetal monitoring, diagnostics, and predictive testing. It consists of a series of physician prescribed tests for monitoring maternal and foetal health. The current invasive technologies such as CVS and amniocentesis that are used to detect chromosomal abnormalities pose serious risks of miscarriages and are being replaced by the non-invasive prenatal diagnostics technologies. Although NIPD is a relatively nascent segment of the prenatal diagnostics, it presents a lucrative growth potential to industry participants. The segment is mainly supported by rising incidences of foetal health-related abnormalities and the urgent need for safe, accurate and early diagnosis. Products such as MaterniT21 Plus, Verifi, and Harmony prenatal tests are the current tests available in the market. Around 100,000 samples were likely tested by MaterniT21 plus test alone by the first quarter of 2013 since its launch. Further the report US Non-Invasive Prenatal Diagnostics - Market Insight, provides a transparent view on the present regulatory framework elaborating on the existing loopholes. A thorough analysis has been done illustrating the views of regulatory authorities, players and consumers towards the regulatory stringency, and the direction of regulations in the future have also been covered. Currently, the US NIPD sector is characterized by the presence of players like Sequenom, Verinata, Ariosa and Natera. These companies are effectively taking steps to promote their LDTs among the US population especially targeting physicians to recommend their products. In future, the launch of Natera's test is expected to impact the market significantly, thereby boosting the potential size and sample volume. Companies Mentioned: - Ariosa Diagnostics - Natera - Sequenom - Verinata For more information visit http://www.researchandmarkets.com/research/bk...oninvasive About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
2014 Analysis of the UK Hepatitis Diagnostics Market: Hospitals, Blood Banks, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
M2 - Mon Mar 10, 6:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rjsvbf/2014_analysis_of) has announced the addition of the "2014 Analysis of the UK Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures" report to their offering. The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals - Commercial/Private Labs - Blood Banks - Public Health Labs In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio/Innogenetics - Hologic/Gen-Probe - ID Biomedical/GSK - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics/Grifols - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/rj...nalysis_of About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Sequenom Announces Changes In Company Leadership
PR Newswire - Wed Mar 05, 6:00PM CST
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that Harry F. Hixson, Jr., Ph.D., will retire as Chief Executive Officer (CEO), effective as of the Company's 2014 Annual Meeting on June 10, 2014. William J. Welch, the Company's current President and Chief Operating Officer, will assume the role of CEO, effective as of the Annual Meeting and immediately upon Dr. Hixson's retirement as CEO.
Sequenom, Inc. Announces Participation At The 26th Annual Roth Conference
PR Newswire - Mon Mar 03, 6:00AM CST
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the 26th Annual Roth Conference at the Ritz Carlton in Dana Point, CA on March 9-12, 2014.
Why Sequenom (SQNM) Closed Lower on Friday
at The Street - Fri Feb 28, 3:45PM CST
Sequenom (SQNM) closed lower on Friday after quarterly revenue came in below expectations.
Hot Stock: Sequenom, Shares Drop 9.1% (SQNM)
Comtex SmarTrend(R) - Fri Feb 28, 10:13AM CST
Sequenom (NASDAQ:SQNM) is one of today's worst performing low-priced stocks, down 9.1% to $2.34 on 1.0x average daily volume. Sequenom has traded 2.0 million shares thus far today, vs. average volume of 1.9 million shares per day. The stock has underperformed the Dow (-9.1% to the Dow's 0.6%) and underperformed the S&P 500 (-9.1% to the S&P's 0.6%) during today's trading.
Concise Analysis of the International Genetic Testing Market
M2 - Fri Feb 28, 8:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/8z6k4n/global_genetic) has announced the addition of the "Concise Analysis of the International Genetic Testing Market" report to their offering. Currently, DTC genetic testing is the buzz word in the Global Genetic Testing market. DTC genetic testing refers to genetic tests that are marketed directly to consumers through television, print advertisements, or the internet. This form of testing, which is also called at-home genetic testing, provides access to a person's genetic information without the involvement of the consumer's healthcare provider. The DTC test typically includes collecting a DNA sample at home, often by swabbing the inside lining of the cheek, and mailing the sample back to the laboratory. Consumers are notified of their results by e-mail, over the phone, or the results are posted online on the websites of the offering companies. DTC genetic tests are expected to have a positive impact on the growth of the market during the forecast period. According to the report, one of the main drivers in this market is the increase in the aging population worldwide. The increasing prevalence of diseases such as diabetes, obesity, and cancer among the elderly population is contributing to the growth of the market. Further, the report states that one of the major challenges in the market is the lack of a credible standard procedure to evaluate the analytic and clinical validity of genetic tests. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Geographical Segmentation 8. Key Leading Countries 9. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis Companies Mentioned: - Abbott Laboratories - Agilent Technologies Inc. - Clarient Inc. - Genomic Health Inc. - Hologenic Inc. - Myriad Genetics Inc. - Qiagen N.V. - Quest Diagnostics Inc. - Roche Holding AG - Sequenom Inc. - Transgenomic Inc. - bioM?rieux SA For more information visit http://www.researchandmarkets.com/research/8z...al_genetic
Sequenom's Q4 Loss Narrows 42% on Higher Laboratory Revenue
Sean Williams, The Motley Fool - Motley Fool - Thu Feb 27, 4:14PM CST
Small-cap life science company Sequenom reported its fourth-quarter earnings results after the closing bell tonight, highlighting a push toward smaller losses and lower cash burn. For the quarter, Sequenom reported a 34% increase in revenue to...
Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year Of 2013
PR Newswire - Thu Feb 27, 3:10PM CST
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, today reported total revenues of $45.1 million for the fourth quarter and $162.4 million for the full year of 2013. Net loss was $18.9 million, or $0.16 per share, for the fourth quarter and $107.4 million, or $0.93 per share, for the full year.
3 Biotech Stocks Under $10 to Trade for Breakouts
at The Street - Wed Feb 26, 5:00AM CST
These under-$10 biotech stocks are within range of triggering breakout trades.
Emerging Indian NIPT Market: 2014 Report Reveals that in India, NIPT Will Be Eagerly Adopted by the Booming IVF Clinics
M2 - Tue Feb 25, 12:10PM CST
Research and Markets (http://www.researchandmarkets.com/research/p8gdfv/emerging_indian) has announced the addition of the "Emerging Indian NIPT Market" report to their offering. In the latest research study Emerging Indian NIPT Market, the analysts have identified various factors to showcase the immense potential of the Indian NIPT market. These factors like the number of births by the age of mother, rural and urban split of such births; affordability for NIPT; and regulatory scenario have been prudently analyzed to reflect a clear picture of the immense possibilities in the Indian NIPT market. The report provides a depiction of macro-economic factors and healthcare infrastructure relevant in the context of NIPT. The study reveals that in India, NIPT will be eagerly adopted by the booming IVF clinics that are witnessing a huge surge in fertility tourism. Also, India is home to a rapidly expanding network of pathology labs. In order to differentiate themselves from competition, organized players in the Indian diagnostic services market are looking forward to adopting new tests. RNCOS has used its expertise in the Indian IVF and diagnostic services market to provide a relevant snapshot of these markets in the report. Leading players in both markets have been profiled with details about their infrastructure and analysis of their strengths and weaknesses, which will prove to be of value to NIPT players looking for partnering opportunities in India. Besides, to offer a glimpse of NIPT players in the global market to the diagnostic services players looking forward for partnerships and collaborations, detailed profiling of NIPT players, including the description of their test offering along with strengths and weaknesses analysis of their NIPT business has been provided. The report also includes the findings from another RNCOS survey namely Gynecologists survey to assess the potential for NIPT in India. The survey was done between September-December 2012 with around 100 leading gynecologists in India. The key findings reveal that currently the awareness level of NIPT is very low in India. But when made aware about the benefits of NIPT, all gynecologists agreed that if launched tactfully, such a technology would have a tremendous scope to revolutionize the prenatal diagnosis scenario in India. Companies Mentioned: -Ariosa Diagnostics -Berry Genomics -BGI -Dr. Lal Pathlabs -Metropolis India -Natera -Quest Diagnostics -Sequenom -SRL Diagnostics -Thyrocare -Verinata For more information visit http://www.researchandmarkets.com/research/p8...ing_indian About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Prenatal Testing Market in the US 2014-2018: Perkinelmer Inc. Expands its Screening Test Offerings, Introducing the First Early Onset Preeclampsia Screening Test in the US in 2013
M2 - Tue Feb 25, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/x2lvh8/prenatal_testing) has announced the addition of the "Prenatal Testing Market in the US 2014-2018" report to their offering. The analysts forecast the Prenatal Testing market in the US to grow at a CAGR of 5.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of fetal health-related abnormalities. The Prenatal Testing market in the US has also been witnessing the significant increase in the launch of new tests. However, the falling fertility rates in the US could pose a challenge to the growth of this market. Key vendors dominating this space are PerkinElmer Inc., Quest Diagnostics Inc., Sequenom Inc., and Verinata Health Inc. Other vendors mentioned in the report are ANGLE plc, Ariosa Diagnostics Inc., BGI Health, CellScape Corp., Fluidigm Corp., Ikonisys Inc., Kellbenx Inc., Natera Inc., Ravgen Inc., and Trovagene Inc. Commenting on the report, an analyst from the team said: The Prenatal Testing market in the US is experiencing a significant increase in the number of new tests being launched in the market. For instance, Sequenom launched Laboratoire Cerba's non-invasive prenatal test in San Diego, California, and Saint-Ouen-L'Aumone, France, in December 2013 and enhanced the sequencing series for its MaterniT21 PLUS laboratory-developed test in October 2013. Moreover, PerkinElmer Inc. expanded its prenatal screening test offerings, introducing the first early onset preeclampsia screening test in the US in August 2013. This trend will have a positive impact on the growth of the market. According to the report, one of the major factors driving the market is the increase in the incidence of fetal abnormalities such as Down syndrome, Edwards syndrome, neural tube defects, and genetic defects and disorders such as sickle cell anemia, thalassemia, spina bifida, Tay Sachs disease, cystic fibrosis, muscular dystrophy, cleft palate and fragile X syndrome. For more information visit http://www.researchandmarkets.com/research/x2...al_testing About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Respiratory Diseases in the US 2014: Market Outlook and Emerging Opportunities
M2 - Fri Feb 21, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/3tw5kb/respiratory) has announced the addition of the "Respiratory Diseases in the US 2014: Market Outlook and Emerging Opportunities" report to their offering. This new 283-page report presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial, and Public Health Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for microbiology testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.. Methodology - The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. - In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as the author's proprietary data files was conducted. Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - BioRad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio - GenProbe - Hologic - ID Biomedical Innogenetics/Solvay - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics - OrthoClinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac - Wako For more information visit http://www.researchandmarkets.com/research/3t...espiratory About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
2014 Automated Microbiology Market -- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Blood Culture, Urine Screening and Immunodiagnostics
M2 - Tue Feb 18, 8:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/48jvmv/2014_automated) has announced the addition of the "2014 Automated Microbiology Market -- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report to their offering. '2014 Automated Microbiology Market--A Global Strategic Outlook' is a new seven-country strategic analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, and country; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies. Worldwide Market Overview - Estimated universe of laboratories performing microbiology testing by country. - Specimen, test volume and sales forecasts by country. Market Segmentation Analysis - Sales and market shares for major suppliers by individual test and country. - Volume and sales forecasts for over 100 infectious disease assays by individual test and country. - Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy). - Review of the market dynamics, trends, structure, size, growth and major suppliers by country Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Exact Sciences - Fujirebio/Innogenetics - Hologic/Gen-Probe - Illumina - ID Biomedical/GSK - Kreatech - Li-Cor Biosciences - Life Technology - Lonza - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Novartis Diagnostics/Grifols - Orchid CellMark - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Sierra Molecular - Shimadzu - Takara Bio - Tecan - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/48..._automated About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Respiratory Diseases in the UK 2014: Market Outlook and Emerging Opportunities Available Now for Analysis
M2 - Mon Feb 17, 6:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/38644v/respiratory) has announced the addition of the "Respiratory Diseases in the UK 2014: Market Outlook and Emerging Opportunities" report to their offering. This new 281-page report presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for microbiology testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology - The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. - In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as the author's proprietary data files was conducted. Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - BioRad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio - GenProbe - Hologic - ID Biomedical Innogenetics/Solvay - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics - OrthoClinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac - Wako For more information visit http://www.researchandmarkets.com/research/38...espiratory About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2013 Financial Results And Conference Call
PR Newswire - Thu Feb 13, 6:00AM CST
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the fourth quarter and full year of 2013 after closing of the NASDAQ Global Market on Thursday, February 27, 2014.
2014 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts
M2 - Thu Feb 13, 3:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/8tlq3p/2014_analysis_of) has announced the addition of the "2014 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts " report to their offering. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets: - Hospitals - Commercial/Private Labs - Blood Banks - Physician Offices - Public Health Labs For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Key Topics Covered: I. Introduction II. Hepatitis Worldwide Market and Technology Overview III. France: Market Size, Growth and Major Suppliers' Sales and Market Shares IV. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares V, Italy: Market Size, Growth and Major Suppliers' Sales and Market Shares VI. Spain: Market Size, Growth and Major Suppliers' Sales and Market Shares VII. UK: Market Size, Growth and Major Suppliers' Sales and Market Shares X. Alternative Market Penetration Strategies XI. Potential Market Entry Barriers and Risks XII. Competitive Assessments Companies Mentioned: - Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Fujirebio/Innogenetics - Hologic/Gen-Probe - ID Biomedical/GSK - Kreatech - Life Technology - Lonza - Nanogen/Elitech - Novartis Diagnostics - Ortho-Clinical Diagnostics - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Takara Bio - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/8t...nalysis_of
2014 Analysis of the US Hospital Cancer Diagnostics Market
M2 - Thu Feb 13, 3:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/g5hk8t/2014_analysis_of) has announced the addition of the "2014 Analysis of the US Hospital Cancer Diagnostics Market" report to their offering. This new report contains 533 pages, 43 tables, and presents a comprehensive analysis of the US hospital cancer diagnostics market, including: - Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. - Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. - Test volume and sales forecasts for 40 cancer diagnostic procedures performed in French hospitals. - Current instrumentation technologies and feature comparison of leading analyzers. - Sales and market shares of leading suppliers. - Emerging diagnostic technologies and their potential market applications. - Product development opportunities. - Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. - Business opportunities and strategic recommendations for suppliers. Key Topics Covered: Introduction Worldwide Market and Technology Overview A. Cancer Statistics and Etiology B. Major Current And Emerging Cancer Diagnostic Tests C. Instrumentation Review And Market Needs D. Current and Emerging Technologies US A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers Major Product Development Opportunities A. Reagent Kits and Test Systems/Panels B. Instrumentation C. Computers, Software and Automation D. Auxiliary Products Design Criteria for Decentralized Testing Products Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies 1. Marketing Approaches 2. Product Complexity 3. Customer Preference 4. Established Suppliers 5. Emerging Suppliers 6. Major Types of Distributors 7. Market Segmentation Factor Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges Companies Mentioned: - Abbott - AdnaGen - Applied Gene Technologies - Arca - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics - bioMerieux - Bio-Rad - Cepheid - Correlogic Systems - Dako - Decode - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Enterix - Enzo Biochem - Epigenomics - Exact Sciences - Fujirebio - Gen-Probe - Guided Therapeutics - Hologic - Ipsogen - Kreatech - Kyowa Medex - Life Technologies - Mackay Life Sciences - Myriad Genetics - Nanogen Elitech - OncoLab - Otho-Clinical Diagnostics - Panacea Pharmaceuticals - Polartechnics - Polymedco - PreMD - Qiagen - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila For more information visit http://www.researchandmarkets.com/research/g5...nalysis_of
Genetic Testing Market Likely to Grow at a CAGR of Around 9% During 2012-2017
M2 - Tue Feb 11, 9:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/qnk984/genetic_testing) has announced the addition of the "Genetic Testing Market Outlook to 2017" report to their offering. A recent report, Genetic Testing Market Outlook to 2017, provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principles and types are covered in around a 140-page report. On account of our analysis of the past and present market trends; drivers; and existing strengths and challenges; forecast for genetic testing has been drawn, according to which, the market is likely to grow at a CAGR of around 9% during 2012-2017. The report is an outcome of extensive interaction with industry experts which has led us to portray the updated status of genetic testing in various therapeutic areas, major geographies and significant industry applications. The genetic testing industry has seen several new product launches, active research innovations, strategic activities, launch of new DTC tests, and wider therapeutic applications. The report effectively illustrates the role of genetic testing in diseases such as Cancer, Cystic Fibrosis and Alzheimer. It also incorporates the information on disease prevalence, available tests, and genes that cause a particular disease. An extensive research and reliable statistics in terms of market size, developments and future performance for emerging sectors namely, Next-Generation Sequencing, Whole Genome Sequencing, Non Invasive Prenatal Diagnostics, and Personalized Medicine have been covered in the report. Genetic testing is growing in both developing and developed nations with both industry and research personnel highlighting the significance of molecular biology. The report provides comprehensive analytics of key developments for major markets including the U.S., Europe and Asian countries, and their market overview. Country level analysis depicts the level of penetration for genetic testing, types of tests available, consumer perspectives, regulatory stringency and future growth. Companies Mentioned: - Abbott Laboratories - Clarient (GE Healthcare) - Dako (Agilent Technologies) - Genomic Health - Genoptix (Novartis) - Gen-Probe (Hologic) - Life Technologies Corporation - Myriad Genetics - Quest Diagnostics - Roche Diagnostics - Sequenom - Transgenomic For more information visit http://www.researchandmarkets.com/research/qn...ic_testing About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
2014 Analysis of the World Cancer Diagnostic Testing Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
M2 - Mon Feb 10, 2:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/r66j8d/2014_analysis_of) has announced the addition of the "2014 Analysis of the World Cancer Diagnostic Testing Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities" report to their offering. This new report contains 1,200 pages, 450 tables and provides forecasts for 40 tumor markers by country and market segment, as well as sales and market shares for reagent and instrument suppliers. The report is available by region, country, section, market segment and individual test: Regions: Global, Europe Countries: France, Germany, Italy, Japan, Spain, UK, USA Sections: Assays, Competitors, Instrumentation, Technologies Market Segments: Hospitals (France, Germany, Italy, Japan, Spain, UK, USA), Personalized Testing Tests: AFP, Beta-2 Microglobulin,CA Tumor Markers, CEA, Cell Surface Markers, Occult Blood, PAP, Pap Smear/HPV, PSA To purchase a DataPack that includes (test volumes, sales forecasts, supplier shares) please E-mail us. Key Topics Covered: Introduction Worldwide Market and Technology Overview A. Cancer Statistics and Etiology B. Major Current And Emerging Cancer Diagnostic Tests C. Instrumentation Review And D. Current and Emerging Technologies Competitive Profiles - Abbott - AdnaGen - Applied Gene Technologies - Arca - Beckman Coulter/Danaher - Becton Dickinson - Bio-Rad - Biomedical Diagnostics - Cepheid - Correlogic Systems - Dako - Decode - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Enterix - Enzo Biochem - Epigenomics - Exact Sciences - Fujirebio - Gen-Probe - Guided Therapeutics - Hologic - Ipsogen - Kreatech - Kyowa Medex - Life Technologies - Mackay Life Sciences - Myriad Genetics - Nanogen Elitech - OncoLab - Otho-Clinical Diagnostics - Panacea Pharmaceuticals - Polartechnics - Polymedco - PreMD - Qiagen - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila - bioMerieux For more information visit http://www.researchandmarkets.com/research/r6...nalysis_of About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
(0)
(0)Sequenom Inc. (SQNM) Stock Research Links
Scroll down for more posts ▼